[1] 毛开云,范月蕾,王跃,等.间充质干细胞治疗产品开发现状与趋势[J].中国生物工程杂志,2017,37(10):126-134.
[2] LISINI D, NAVA S, POGLIANI S, et al. Adipose tissue-derived mesenchymal stromal cells for clinical application: an efficient isolation approach. Curr Res Transl Med. 2018;10(18):2452-3186.
[3] ANGELOPOULOS I, BRIZUELA C, KHOURY M. Gingival mesenchymal stem cells outperform haploidentical dental pulp-derived mesenchymal stem cells in proliferation rate, migration ability, and angiogenic potential. Cell Transplant. 2018;27(6):967-978.
[4] GASIŪNIENĖ M, PETKUS G, MATUZEVIČIUS D, et al. Angiotensin II and TGF-β1 Induce Alterations in Human Amniotic Fluid-Derived Mesenchymal Stem Cells Leading to Cardiomyogenic Differentiation Initiation. Int J Stem Cells. 2019;12(2):251-264.
[5] GASIŪNIEN M, VALATKAIT E, NAVAKAUSKIEN R. Long‐term cultivation of human amniotic fluid stem cells: the impact on proliferative capacity and differentiation potential. J Cell Biochem. 2020;121(7):3491-3501.
[6] TOPOLUK N, HAWKINS R, TOKISH J, et al. Amniotic mesenchymal stromal cells exhibit preferential osteogenic and chondrogenic differentiation and enhanced matrix production compared with adipose mesenchymal stromal cells. Am J Sports Med. 2017;45(11):2637-2646.
[7] YANG L, ZHU S, LI Y, et al. Overexpression of Pygo2 Increases Differentiation of Human Umbilical Cord Mesenchymal Stem Cells into Cardiomyocyte-like Cells. Curr Mol Med. 2020;20(4):318-324.
[8] 冯国纹,余丽梅.人羊膜应用的研究进展[J].生物医学工程学杂志,2014, 31(4):930- 934.
[9] ALONSO-CARPIO M, SÁNCHEZ-GARCÍA A, TRAPERO A, et al. Use of amniotic membrane as a biological dressing for the treatment of torpid venous ulcers: a case report. use of amniotic membrane as a biological dressing for the treatment of torpid venous ulcers: a case report. Plast Surg Nurs. 2020;40(3):135-137.
[10] PHERMTHAI T, THONGBOPIT S, POKATHIKORN P, et al. Carcinogenicity, efficiency and biosafety analysis in xeno-free human amniotic stem cells for regenerative medical therapies. Cytotherapy. 2017;19(8):990-1001.
[11] Adamowicz J, Pasternak I, Kloskowski T, et al. Development of a conductive biocomposite combining graphene and amniotic membrane for replacement of the neuronal network of tissue-engineered urinary bladder. Sci Rep. 2020;10(1):5824.
[12] 卢世璧,吴祖泽,付小兵,等.中国细胞技术类再生医学创新型技术产业发展战略研究[J].中国工程科学,2017,19(2):95-99.
[13] 吴祖泽.致细胞库质量管理规范制定和公示[J].中国医药生物技术, 2017,12(6):483.
[14] KEHL D, GENERALI M, GORTZ S, et al. Amniotic fluid cells show higher pluripotency-related gene expression than allantoic fluid cells. Stem Cells. 2017;26(19):1424-1437.
[15] EMANUEL K, KATARZYNA K, HALINA KK, et al. Increased immunomodulatory capacity of human amniotic cells after activation by pro-inflammatory chemokines. Eur J Pharmacol. 2019;859:172545.
[16] SPRINGER SCIENCE+BUSINESS MEDIA, LLC. Retraction note: can two-way direct communication protocols be considered secure? Nanoscale Res Lett. 2019;14(1):242.
[17] FAN X, LI L, YE Z, et al. Regulation of osteogenesis of human amniotic mesenchymal stem cells by sodium butyrate. Cell Biol Int. 2018;42(4): 457-469.
[18] FOUAD H, SABRY D, ELSETOHY K, et al. Therapeutic efficacy of amniotic membrane stem cells and adipose tissue stem cells in rats with chemically induced ovarian failure. J Adv Res. 2016;7(2):233-241.
[19] CHAI HH, CHEN MB, CHEN GZ, et al. Inhibitory effect of TGF-β gene modified human amniotic mesenchymal stem cells on rejection after xenotransplantation of peripheral nerves. Eur Rev Med Pharmacol Sci. 2019; 23:3198-3205.
[20] 齐斌,余丽梅.人羊膜间充质干细胞衰老改变及miRNA和mRNA差异表达分析[D].遵义:遵义医学院,2015.
[21] 王钰莹,粟旭,刘波,等.人羊膜间充质干细胞原位移植治疗大鼠脑梗死[J].中国组织工程研究,2017,21(9):1414-1419.
[22] 张哲,曾宪卓,鲁飞,等.无血清培养人胚胎干细胞的体系研究与进展[J].中国组织工程研究,2015,41(19):6711-6717.
[23] TSAI HH, YANG KC, WU MH, et al. The effects of different dynamic culture systems on cell proliferation and osteogenic differentiation in human mesenchymal stem cells. Int J Mol Sci. 2019;20(16):4024.
[24] HAYASHI Y, FURUE MK. Biological effects of culture substrates on human pluripotent stem cells. Stem Cells Int. 2016;2016:5380560.
[25] SATO K, ITOH T, KATO T, et al. Serum-free isolation and culture system to enhance the proliferation and bone regeneration of adipose tissue-derived mesenchymal stem cells. In Vitro Cell Dev Biol Anim. 2015;51(5):515-529.
[26] 韩颢.脐带间充质干细胞无血清培养方案的优化[D].天津:天津医科大学,2019.
[27] 屈玟,宋磊,赵瑶,等.人脐带间充质干细胞不同培养方案的比较与优化[J].海南医学院学报,2017,23(8):1009-1013.
[28] Hoang VT, Trinh QM, Phuong DTM, et al. Standardized xeno- and serum-free culture platform enables large-scale expansion of high-quality mesenchymal stem/stromal cells from perinatal and adult tissue sources. Cytotherapy. 2021;23(1):88-99.
[29] CARMELO JG, FERNANDES-PLATZGUMMER A, DIOGO MM, et al. A xeno-free microcarrier-based stirred culture system for the scalable expansion of human mesenchymal stem/stromal cells isolated from bone marrow and adipose tissue. Biotechnol J. 2015;10(8):1235-1247.
[30] BUI HTH, NGUYEN LT, THAN UTT, et al. Influences of xeno-free media on mesenchymal stem cell expansion for clinical application. Tissue Eng Regen Med. 2021;18(1):15-23.
[31] 余丽梅.一种完全培养基培养羊膜间充质干细胞的方法[P].中国专利: 201110080968.6, 2013-07-24.
[32] 穆思婕,于泓.人羊膜间充质干细胞体外上调类风湿关节炎患者外周血Treg细胞比例[D].遵义:遵义医学院,2015.
[33] Wang AT, Zhang QF, Wang NX, et al. Cocktail of hyaluronic acid and human amniotic mesenchymal cells effectively repairs cartilage injuries in sodium iodoacetate-induced osteoarthritis rats. Front Bioeng Biotechnol. 2020;6(8):87.
[34] Giada P, Anabel F, Mariangela P, et al. Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic rats. Liver Int. 2020;40(10):2500-2514.
[35] 平崎诚司.美国Geron公司实施胚胎干细胞治疗脊髓损伤的临床试验[J].生物产业技术,2011(1):6.
[36] DA CRUZ L, FYNES K, GEORGIADIS O, KERBY J, et al. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotechnol. 2018;36(4):328-337.
[37] CARDOSO1 MT, PINHEIRO1 AO, VIDANE AS, et al. Characterizaton of teratogenic potental and gene expressionin canine and feline amniotc membrane-derived stem cells. Origin alarticle. 2017;52(2):58-64.
[38] WANG JY, WU PK, CHEN PC, et al. Generation of Osteosarcomas From a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells. Stem Cells Transl. 2017;6(2):512-526.
[39] GAGGI G, DI CREDICO A, IZZICUPO P, et al. Epigenetic features of human perinatal stem cells redefine their stemness potential. Cells. 2020;9(5):1304.
[40] 张可华,纳涛,刘静,等.建立间充质干细胞制剂质量控制评价体系[C].2013中国生物制品年会暨第十三次全国生物制品学术研讨会论文集.2013:317-318.
[41] 孙丽娟.脐带间充质干细胞制剂制备及质量控制[J].沈阳药科大学学报, 2020,289(2):79-83.
[42] 中国医药生物技术协会.干细胞制剂制备质量管理自律规范[J].中国医药生物技术,2016,11(6):481-490.
[43] Liu H, Li R, Liu T, et al. Immunomodulatory effects of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles in rheumatoid arthritis. Front Immunol. 2020;11:1912.
[44] PIEROZAN P, CATTANI D, KARLSSON O. Hippocampal neural stem cells are more susceptible to the neurotoxin BMAA than primary neurons: effects on apoptosis, cellular differentiation, neurite outgrowth, and DNA methylation .Cell Death Dis. 2020;11(10):910.
[45] 王立生,吴祖泽.精准医学时代的细胞治疗[J].齐鲁医学杂志,2018, 33(2):95-97.
[46] THOMPSON AA, WALTERS MC, KWIATKOWSKI J, et al. Gene therapy in patients with transfusion-dependent β-thalassemia. N Engl J Med. 2018;378 (16):1479-1493.
[47] STIRNADEL-FARRANT H, KUDARI M, GARMAN N, et al. Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID. Orphanet J Rare Dis. 2018;13(1):49-59.
|